In today’s COVID-19 environment, more than ever, the myMatrixx team understands how to innovate and adapt to the changing workforce conditions. Our mission, to provide you with the highest level of customized service, has never been more important. We care deeply about our partners and their injured workers, and we are committed to providing you with the comprehensive information and resources you need to make decisions to support and grow your business.
Please use this resource to stay informed on how myMatrixx is addressing COVID-19 and check in often, as this page is updated frequently.
Image
COVID-19 Helpful Resources
Learn what the Coronavirus is, how it started, symptoms, prevention, and more:
COVID-19 Position Paper
myMatrixx View on COVID-19 Vaccination and Workers' Compensation Coverage
New York Extends Formulary Compliance Date for Refill Medications
November 18, 2020
The New York State Workers’ Compensation Board has announced that it will be extending the date for refill compliance with the formulary beyond January 1, 2021. A new date, which is likely to be in spring 2021, will be announced soon.
Learn more
COVID-19 Pandemic Parallels: myMatrixx & Publix Present at WCI Virtual Fall Webinar
November 13, 2020
myMatrixx, presents a new panel on the increasing use of psychotropic drugs among injured workers at WCI Virtual Reboot Seminar.
Learn more
Update to Search for Safe and Effective COVID-19 Vaccines Document
November 09, 2020
One of the top priorities for successfully mitigating COVID-19 is the development of an effective yet safe vaccine. Currently there are more than 100 potential vaccines in development, with projections for commercial availability a year or more away. To provide the latest information, myMatrixx is...
Learn more
FDA Approves First Drug for Treatment of COVID-19
October 23, 2020
Gilead Sciences received full U.S. Food and Drug Administration (FDA) approval on Oct. 22, 2020, for Veklury® (remdesivir) injection. Remdesivir is to be marketed under brand name Veklury.
Learn more
Making Sense of Workers’ Comp Pharmaceuticals During COVID-19
August 10, 2020
When the COVID-19 pandemic became a serious concern all the way back in March, businesses had to find a way to adapt. Since it is abundantly clear that this is in no way a short-term problem, it is all the more critical to start to look back and analyze some of the data from the earlier months. ...
Learn more
myMatrixx Discusses Ongoing Impact of COVID-19 for Express Scripts Outcomes Summer Series
August 07, 2020
myMatrixx assembles a panel of leading industry experts to discuss the impact of COVID-19 on workers' compensation in a virtual presentation for the Express Scripts Outcomes Summer Series.
Learn more
MedWatch Update on Hand Sanitizers
July 24, 2020
During June and July, the FDA has issued a series of warnings that some commercial hand sanitizers contain methanol and it has asked a number of manufacturers to recall their products. Also known as wood alcohol, methanol is intended for industrial use in products such as pesticides and solvents....
Learn more
Update on Dexamethasone Use for COVID-19 Treatment
July 07, 2020
Preliminary results from a randomized, controlled, open-label, adaptive study on the use of dexamethasone were added to myMatrixx’s “Coronavirus Disease 2019 (COVID-19) – The Search for a Treatment” document. The recovery trial compared a ten day course of dexamethasone 6mg once per day versus...
Learn more